Complement 3 Is Involved in the Synthetic Phenotype and Exaggerated Growth of Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats

Vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR) show the synthetic phenotype and exaggerated growth in comparison with VSMCs from normotensive Wistar-Kyoto (WKY) rats. We investigated genes associated with the synthetic phenotype and exaggerated growth of VSMCs from SHR by microarray. Expression of 1300 transcripts was evaluated by microarray with total mRNA extracted from mid-layer aortic smooth muscle of 3-week-old SHR/Izumo and WKY/Izumo rats. mRNAs encoding sodium-dependent neurotransmitter transporter, epidermal growth factor precursor, EEF2, leptin receptor long-isoform b, clathrin assembly protein short form, and preprocomplement 3 (pre-pro-C3) were expressed only in aortic smooth muscle from SHR by microarray and by reverse-transcription polymerase chain reaction analysis. Pre-pro-C3 mRNA was detected only in cultured VSMCs from SHR. Exogenous C3 changed VSMCs to the synthetic phenotype. Antisense oligodeoxynucleotides (ODN) to C3 reduced the higher level of DNA synthesis in VSMCs from SHR. Antisense ODN to C3 increased expression of SM22&agr; mRNA and decreased expression of osteopontin and matrix Gla mRNAs. It also decreased expression of growth factor mRNAs in VSMCs from SHR. In conclusion, we have shown that C3, independent of other complement molecules, has direct effects on the phenotype of VSMCs and stimulates growth of these cells. C3 is produced only by VSMCs from SHR. Therefore, C3 may be the gene underlying the synthetic phenotype and exaggerated growth of VSMCs from SHR. C3 may be a new target for the treatment of hypertension.

[1]  H. Tanijiri.  Cardiac hypertrophy in spontaneously hypertensive rats. , 1975, Japanese heart journal.

[2]  H. Müller-Eberhard,et al.  Anaphylatoxins: C3a and C5a. , 1978, Advances in immunology.

[3]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.

[4]  P. Hamet,et al.  Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. , 1986, Hypertension.

[5]  B. Folkow.  Structure and function of the arteries in hypertension. , 1987, American heart journal.

[6]  M. Mallat,et al.  Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. , 1987, Journal of immunology.

[7]  M. Kazatchkine,et al.  The complement system in atherosclerosis. , 1988, Atherosclerosis.

[8]  P. Hamet,et al.  Abnormalities in Growth Characteristics of Aortic Smooth Muscle Cells in Spontaneously Hypertensive Rats , 1989, Hypertension.

[9]  Y. Misumi,et al.  Nucleotide and deduced amino acid sequence of rat complement C3. , 1990, Nucleic acids research.

[10]  Y. Ishimi,et al.  Transcriptional regulation of the production of the third component of complement (C3) by 1 alpha,25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells. , 1991, Endocrinology.

[11]  B. Spiegelman,et al.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. , 1992, The Journal of biological chemistry.

[12]  P L Weissberg,et al.  Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. , 1993, Circulation research.

[13]  P. Gasque,et al.  Expression of the complement alternative pathway by human myoblasts in vitro , 1994, Journal of Neuroimmunology.

[14]  J. Volanakis.  Transcriptional regulation of complement genes. , 1995, Annual review of immunology.

[15]  K. Ikeda,et al.  Production of the third and fourth component of complement (C3, C4) by smooth muscle cells , 1996 .

[16]  N. Fukuda,et al.  Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. , 1999, Journal of hypertension.

[17]  H. Okada,et al.  mRNA Expression of Complement Components and Regulators in Rat Arterial Smooth Muscle Cells , 1999, Microbiology and immunology.

[18]  NoboruFukuda,et al.  Production of Angiotensin II by Homogeneous Cultures of Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats , 1999 .

[19]  W. Prodinger,et al.  C3 molecules internalize and enhance the growth of Lewis lung carcinoma cells. , 1999, Immunobiology.

[20]  NoboruFukuda,et al.  Phenotypic Modulation by Fibronectin Enhances the Angiotensin II–Generating System in Cultured Vascular Smooth Muscle Cells , 2000 .

[21]  N. Fukuda,et al.  Role of Endogenous Angiotensin II in the Increased Expression of Growth Factors in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats , 2001, Journal of cardiovascular pharmacology.

[22]  C. Come,et al.  Influence of C3 Deficiency on Atherosclerosis , 2002, Circulation.

[23]  N. Fukuda,et al.  Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats , 2002, Journal of hypertension.

[24]  P. Gasque,et al.  Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.